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INTRODUCTION
Cheyne-Stokes respiration (CSR) is a form of periodic
breathing in which central apneas and hypopneas alternate
with periods of hyperventilation, producing a waxing and
waning pattern of tidal volume. This brief case described an
interesting association of CSR and hypertrophic cardiomyo-
pathy (HCM) in a patient with normal left ventricular
ejection fraction, providing physiological insights for the
genesis of CSR.
CASE DESCRIPTION
A 64-year-old male patient was admitted for a routine
cardiac evaluation with complaints of witnessed apnea
during sleep. He had previous history of HCM and
permanent atrial fibrillation. He was on regular use of
carvedilol 50 mg/d; enalapril 40 mg/d, furosemide 80 mg/
d and warfarin 5 mg/d and was on NYHA stage III heart
failure. Echocardiography demonstrated interventricular
septum wall thickness of 20 mm and posterior wall
thickness of 11 mm, without left ventricle outflow tract
obstruction. The left ventricle ejection fraction was in the
normal range (69%). The right ventricle systolic pulmonary
pressure was 35 mmHg. Echocardiographic diastolic func-
tion evaluation was impaired due to atrial fibrillation.
Technetium (99mTc) radionuclide ventriculography showed
normal biventricular systolic function and a median
pulmonary transit time of 13 seconds (normal ,10 seconds),
denoting diastolic dysfunction. Cardiac nuclear magnetic
resonance also demonstrated normal global biventricular
function. Arterial blood gas while awake showed pH:7.41;
pCO2:33 mm Hg; paO2: 78 mm Hg; Sat: 97%; HCO3:
20.6 mMol/L; BE: -2.6 mMol/L. A full-overnight polysom-
nography indicated a sleep efficiency of 95% with pre-
dominantly light sleep (9.9% of stage 1, 75.9% stage 2, 4% of
delta sleep (non REM stage 3/4) and 10.2% stage REM). The
study showed an apnea-hypopnea index of 34.3 events per
hour divided in: obstructive apneas = 8; central apneas =
12.1; mixed apneas = 5.3 and hypopneas = 8.9 events/
hour. CSR pattern of breathing was present during the
entire night (Figure 1). The respiratory pattern character-
istics were averaged over 10 consecutive cycles of apnea at
stage 2 sleep and the results are presented as mean¡SD.
Hyperpnea duration was 42¡3 seconds (calculated as the
time between the beginning of inspiration during the
ventilatory cycle and the onset of the subsequent apnea).
Apnea duration was 19¡3 seconds (defined as the time
between the end of inspiration of the breath preceding a
central apnea and the onset of inspiration of the breath
terminating the apnea) resulting in a cycle duration of 62¡5
seconds (calculated as the sum of the hyperpnea and apnea
durations). The circulation time from the lungs to the
peripheral chemoreceptors was increased (29¡2 seconds-
estimated by measuring the lung-to-ear circulation time
[LECT]), which is the time from the first breath after a
central apnea to the subsequent nadir of SaO2 detected at
the ear by an oximeter. This measure reflects the circulatory
delay due to cardiac dysfunction.
DISCUSSION
HCM is the most common hereditary cardiac disease and
is characterized by left ventricular hypertrophy that may
lead to diastolic heart failure. The annual rate of sudden
cardiac death, the most feared complication of HCM, ranges
from 0.5% to 1.5% per year for most age groups.1 We have
recently reported a high prevalence of obstructive sleep
apnea in 80 consecutive patients with HCM.2 Obstructive
sleep apnea was independently associated with heart
remodeling and atrial fibrillation in this population.
In patients with systolic heart failure, CSR is an
independent marker of poor prognosis3 and may be part
of a vicious cycle, further stressing the failing heart in
patients with congestive heart failure. CSR is characterized
by a prolonged waxing and waning pattern of breathing
interposed by central apneas. CSR has been extensively
described among patients with systolic congestive heart
failure with low ejection fraction. The prevalence of CSR
among patients with systolic congestive heart failure is
strikingly high and ranges from 30% to 50%.3 One of the key
features of CSR is hyperventilation and low arterial PaCO2
that, when it falls below the apnea threshold during sleep,
triggers central apneas.4 Patients with CSR present a low
PaCO2 both awake and asleep. Our patient also presented a
low awake PaCO2 (33 mmHg). The mechanisms leading to
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hyperventilation are not completely understood. Increased
pulmonary capillary vascular pressures may trigger hyper-
ventilation through stimulation of pulmonary vagal affer-
ent-nerve activity. Left ventricular systolic dysfunction
has been suggested as the cause of pulmonary congestion,
but diastolic dysfunction could also lead to pulmonary
congestion. Diastolic dysfunction has also been associated
with increased hypercapnic ventilatory responsiviness.5
Increased chemorreflex could contribute to respiratory
instability due to increased loop gain.3 A previous study
that evaluated 20 patients with diastolic dysfunction found
that 2 patients presented central sleep apnea and CSR
pattern of breathing.6 The present case report extends these
findings by showing that CSR may also be present in
patients with HCM. To the best of our knowledge, this is the
first time this association was presented in a patient with
hypertrophic cardiomyopathy and normal systolic function.
It is important to stress, however, that the presence of atrial
fibrillation is a marker for loss of atrial contraction and poor
cardiac pumping function and may contribute to the genesis
of CSR in the present case.7 Atrial fibrillation is 8 times more
common among patients with central sleep apnea than
among normal controls.8 Another important finding en-
countered in this patients that helps explain the respiratory
pattern is that mean pulmonary transit time was prolonged,
denoting increased circulation time, a hallmark of CSR,
previously described in association with systolic dysfunc-
tion. It also has been found that the duration of hyperpnea is
directly proportional to the lung to peripheral chemorecep-
tor circulation time, and inversely proportional to cardiac
output. Patients with heart failure and CSR present with
the periodic cycle duration averaging approximately 60
seconds, compared with only 35 seconds in patients with
idiopathic central sleep apnea or high-altitude periodic
breathing without heart failure.9 Hall et al.10 compared
central apnea in patients with normal systolic function
versus patients with systolic dysfunction. While the dura-
tion of apnea was similar, patients with normal heart
function presented a significantly shorter hyperpnea and
cycle length time than patients with systolic dysfunction.
The investigators concluded that prolonged periodic breath-
ing cycle and hyperpnea durations, typical of CSR, are a
consequence of left ventricular systolic dysfunction, low
cardiac output, and prolonged circulation time. However,
the patient described presented values of cycle length,
apnea length, and LECT similar to those described in
patients with CSR and heart failure due to systolic
dysfunction:11 hyperpnea time (42 ¡ 3 vs 35 ¡ 7), apnea
time (19¡ 3 vs 27¡ 3), cycle length (62¡ 5 vs 62¡ 10) and
LECT (29¡ 2 vs 27¡ 3). Therefore, we extend the concept
proposed by Hall et al.10 by showing that prolonged
circulation time can also occur in patients with normal left
ventricular systolic function but impaired left ventricular
diastolic function. We conclude that patients with normal
left ventricular function but with severe diastolic dysfunc-
tion and atrial fibrillation may present the typical CSR.
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